Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $5 Million Public Offering of Cel-Sci
Press Release – New York, NY – November 16, 2023 – Sichenzia Ross Ference Carmel LLP announced today that it represented ThinkEquity as the sole book-running manager in a $5.0 million public offering of Cel-Sci, (the “Company”, NYSE American: CVM). Cel-Sci has announced the pricing will equate to approximately 2,490,000 shares of its common stock, at an offering price of $2.00 per share.
Cel-Sci is a biotechnology company, focused on changing the way cancer is treated. Their main focus is the development of novel immune-based therapies, with the potential to utilize the body’s pre-existing immune defense system against disease. Cel-Sci intends to use the net proceeds from this offering to fund the continued development of Multikine, for general corporate purposes, and working capital.
The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Phil Magri.
- Sichenzia Ross Ference Carmel LLP Represents Bousted Securities, LLC and D. Boral Capital LLC in $3.5 Million Private Placement Offering For Kairos Pharma - January 22, 2025
- Sichenzia Ross Ference Carmel LLP (思成律师事务所/SRFC) 代表 Ribbon Acquisition Corp 完成在纳斯达克交易所5000万美元的首次公开发行 (IPO) - January 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management in $600,000 Public Offering of Giftify, Inc. - January 15, 2025